These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 11916246)
1. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization. Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246 [TBL] [Abstract][Full Text] [Related]
2. An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells. Liu JH; Wu SC; Chen WS; Yen CC; Yang MH; Tsai YC; Chen PM Biochem Biophys Res Commun; 2004 Jun; 318(3):764-72. PubMed ID: 15144904 [TBL] [Abstract][Full Text] [Related]
3. [The effect of anti-bcr-abl hammerhead ribozyme on bone marrow purging]. Wu Y; Chen YZ; Huang HF; Chen P; Lu LH Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):859-63. PubMed ID: 12958661 [TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia. Wright L; Wilson SB; Milliken S; Biggs J; Kearney P Exp Hematol; 1993 Dec; 21(13):1714-8. PubMed ID: 8243570 [TBL] [Abstract][Full Text] [Related]
5. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells]. Wu Y; Chen Y; Hu J Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328 [TBL] [Abstract][Full Text] [Related]
6. Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. Shore SK; Nabissa PM; Reddy EP Oncogene; 1993 Nov; 8(11):3183-8. PubMed ID: 8414522 [TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
8. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene. Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector. Sengupta A; Banerjee D; Chandra S; Banerjee S J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195 [TBL] [Abstract][Full Text] [Related]
11. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells. Gross AW; Ren R Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343 [TBL] [Abstract][Full Text] [Related]
12. Antisense inhibition of P210 bcr-abl in chronic myeloid leukemia. Vaerman JL; Lewalle P; Martiat P Stem Cells; 1993 Oct; 11 Suppl 3():89-95. PubMed ID: 8298481 [TBL] [Abstract][Full Text] [Related]
13. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells]. Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468 [TBL] [Abstract][Full Text] [Related]
14. Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia. Leopold LH; Shore SK; Reddy EP Leuk Lymphoma; 1996 Aug; 22(5-6):365-73. PubMed ID: 8882949 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction. Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954 [TBL] [Abstract][Full Text] [Related]
16. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia]. Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985 [TBL] [Abstract][Full Text] [Related]
17. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides]. Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009 [TBL] [Abstract][Full Text] [Related]
19. [The effect of multi-unit ribozymes on the growth inhibition and apoptosis induction of CML K562 cells]. Feng Q; Sun B; Sun K; Shang Z; Wang S; Wang W; Zhao Y; Yan Z; Han W; Zhang Y Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):435-9. PubMed ID: 12485492 [TBL] [Abstract][Full Text] [Related]
20. A small molecule significantly inhibits the bcr/abl fusion gene at the mRNA level in human chronic myelogenous leukemia. He Q; Dong J; Zhen H; Ying Y; Zhang J; Li Q; Li B; Zhou Y Leuk Res; 2011 Aug; 35(8):1074-9. PubMed ID: 21163528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]